COMPANY
Clinical Phase 2
Keywords: ophthalmology retinal diseases blindness Geographic Atrophy Dry Age-related Macular Degeneration Dry Macular Degeneration CPCB-RPE1
Profile checked Oct 10, 2026
Timeline
- Trial start II: A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) source ↗
- Trial start Phase 1/Phase 2: Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD source ↗
Upcoming milestones
- 2027-12 (ESTIMATED) · II · A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) · NCT06557460
Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT06557460 | A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) | II | Recruiting | Aug 1, 2025 | 2027-12 (estimated) |
| NCT02590692 | Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD | Phase 1/Phase 2 | Unknown status (ClinicalTrials.gov) | Feb 16, 2016 | 2019-07 (actual) |
